Nasdaq

Biomind Labs To Redefine Obesity Treatment With Its New BMND06 Candidate Targeting Neurological Pathways

TORONTO, ON / ACCESSWIRE / July 18, 2024 / Biomind Labs Inc. ("Biomind" or the "Company") (CBOE:BMND) (OTC PINK:BMNDF) (FRA:3XI), a leading biotech company dedicated to developing the next-generation ...
Yahoo Finance

Biomind Labs Announces CAD $2.52 Million Private Placement Financing

TORONTO, ON / ACCESS Newswire / January 27, 2026 / Biomind Labs Inc. ("Biomind" or the "Company") (CBOE:BMND)(OTC PINK:BMNDF)(FRA:3XI), a clinical-stage biopharmaceutical company focused on ...
Nasdaq

Biomind Labs Announces Unprecedented Positive Results of Phase 2 Clinical Trial of BMND08 for Depression & Anxiety in Alzheimer’s Disease

TORONTO--(BUSINESS WIRE)-- Biomind Labs Inc. (“Biomind” or the “Company”) (NEO: BMND) (OTC: BMNDF) (FSE: 3XI), a leading biotech company focused on developing the next generation of pharmaceuticals to ...
Yahoo Finance

Biomind Research Corp. and Crosswinds Holdings Inc. Announce Definitive Agreement to Complete Reverse Takeover

Toronto, Ontario--(Newsfile Corp. - February 22, 2021) - Crosswinds Holdings Inc. (TSX: CWI) ("Crosswinds") and Biomind Research Corp. ("Biomind" or the "Company") are pleased to announce the ...
Financial Post

Biomind Labs Announces Positive Initial Results From Its Phase II Trial on Its BMND01 Candidate for Treatment Resistant Depression

“With the conclusion of the dosing sessions, 30 volunteers went through the activities of the proprietary clinical-experimental protocol developed by our scientific team, to verify the safety and ...
PharmiWeb

Biomind Labs Announces Filing of Continuous Disclosure Documents and Appointment of Scott Ackerman to the Board

TORONTO, ON / ACCESS Newswire / November 18, 2025 / Biomind Labs Inc. (the "Company") (CBOE:BMND)(OTC PINK:BMNDF)(FRA:3XI), announces that it has filed the following continuous disclosure documents ...
Financial Post

Biomind Labs Reaches High Purity and Yield of DMT Through an Optimized Extraction Method for Its New Chemical Entity Triptax™

“This achievement marks a new major step in our objective to upgrade the development and production of our own Active Pharmaceutical Ingredients. This method can be scalable to potentially reach an ...
Healio

Biomind completes dosing in phase 2 trial of inhaled therapeutic for TRD

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Biomind Labs Inc. announced the completion of dose ...
Business Wire

Biomind Labs Announces the Completion of the First Sublingual Psychedelic Formulation for Its Drug Candidate BMND08 for Depression and Anxiety in Alzheimer’s Disease

TORONTO--(BUSINESS WIRE)--Biomind Labs Inc. (“Biomind Labs” or the “Company”) (NEO: BMND) (OTC: BMNDF) (FSE: 3XI), a leading biotech company focused on developing the next generation of ...
Business Wire

Biomind Labs Opens a New Clinical Psychedelic Research Facility

TORONTO--(BUSINESS WIRE)--Biomind Labs Inc. (“Biomind Labs” or the “Company”) (NEO: BMND) (OTC: BMNDF) (FSE: 3XI), a leading biotech company focused on innovation and research on endogenous ...
Inc

Another Thing A.I. Can Do Now? Diagnose Cancer Better Than Doctors

Ok, now slap yourself awake. The world you dreamed and the one in front of your eyes should match, because as Xinhua reports, the AI system BioMind already has defeated a 15-member team of Chinese ...